Skip to main content
. 2007 Apr 11;56(11):1765–1774. doi: 10.1007/s00262-007-0320-5

Fig. 1.

Fig. 1

HLV FL plus IC effect on NXS2 tumor growth. Groups (n = 4) of A/J mice were injected with 5 × 106 NXS2 cell i.d. on day 0 and received a no treatment, b 200 μg mFL DNA by HLV in both hind limbs on d 3, c 10 μg/d hu14.18-IL-2 IC (day 11–14), or d both FL DNA + IC. Small (FL) and large (IC) arrows indicate HLV gene delivery and hu14.18-IL-2 treatment initiation dates, respectively. f Mice that had received FL + IC (i.e., same animals use in panel d) were rechallenged with NXS2 tumor 70 days later and compared to e naïve mice for tumor progression. Data represent NXS2 tumor growth for individual animals